Novel pre-revenue startups lack a reliable method to determine valuation and raise capital because traditional approaches require market comparables or traction data, and investors perceive them as too risky.
Founders of pre-revenue startups with novel technology lack a reliable method to determine company valuation and raise capital in the absence of market comparables or traction data.
"Where does the valuation come from? How do you know whether to value it at 100k, 1m, 10m, or 100m?"
postHow do you fundraise when knowing the valuation is impossible (I will not promote)
"it's too risky investing in the first to market, let someone else prove it then do it better"
commentI had this problem before, i created a digital age verification app in the UK 6 years ago ... no others existed except Yoti who done KYC and Digital ID. When we went for investment we had nothing to compare it to and most investors said "it's too risky investing in the first to market, let someone else prove it then do it better".
"Valuation at pre-revenue pre-market stage is not a science"
commentValuation at pre-revenue pre-market stage is not a science and anyone who tells you otherwise is either confused or trying to take advantage of you. The honest answer is that early stage valuation is a negotiation anchored by three things ie how much you need to reach the next meaningful milestone, how much dilution you are willing to accept and what comparable deals in your space have looked like recently. You work backwards from those three numbers and that gives you a range rather than a precise figure and that range is your starting point for the conversation. The more important question is not what the valuation is but whether the investor believes the upside justifies the risk and at pre-revenue that belief is almost entirely based on the founder and the technology credibility rather than the numbers. If VCs are taking calls with you then you have cleared that first bar and the valuation conversation becomes a function of how well you can articulate what the capital will do and what the company looks like when it does it. SAFE notes sidestep the valuation question entirely at early stage by deferring it to the next priced round which is often the cleanest solution when the number is genuinely impossible to justify with data. Worth understanding that option if you have not already.
"valuation is mostly a negotiation anchor, not something precise"
commentAt that stage, valuation is mostly a negotiation anchor, not something precise. If there’s no market signal yet, investors price risk, not just the tech. What helps is showing who will pay, how fast you can get there, and what breaks if you wait. You’re really selling the path to traction, not just the invention.
"SAFE notes sidestep the valuation question entirely at early stage"
commentValuation at pre-revenue pre-market stage is not a science and anyone who tells you otherwise is either confused or trying to take advantage of you. The honest answer is that early stage valuation is a negotiation anchored by three things ie how much you need to reach the next meaningful milestone, how much dilution you are willing to accept and what comparable deals in your space have looked like recently. You work backwards from those three numbers and that gives you a range rather than a precise figure and that range is your starting point for the conversation. The more important question is not what the valuation is but whether the investor believes the upside justifies the risk and at pre-revenue that belief is almost entirely based on the founder and the technology credibility rather than the numbers. If VCs are taking calls with you then you have cleared that first bar and the valuation conversation becomes a function of how well you can articulate what the capital will do and what the company looks like when it does it. SAFE notes sidestep the valuation question entirely at early stage by deferring it to the next priced round which is often the cleanest solution when the number is genuinely impossible to justify with data. Worth understanding that option if you have not already.
First-time technology founders building market-first products with no comparable companies, struggling to set a credible valuation and attract investors.
The same complaint appears multiple times: valuation is guesswork, investors are risk-averse for novel tech, and SAFEs are a band-aid.
Uses AI-driven analysis of non-financial factors (IP, tech novelty, team pedigree) to compute a valuation range where comparable analysis fails, combined with a curated investor network specifically willing to fund market-first bets.
An AI-powered platform that generates a defensible valuation range by analyzing non-traditional signals (IP strength, team, market, tech moat) and matches founders with investors open to first-to-market risk, providing a seamless path to SAFE-based fundraising.
Founders currently resort to arbitrary numbers or expensive advisors; a tool that reduces fundraising friction and connects them to aligned investors directly addresses the core pain expressed in comments—$99 is under 1% of a typical seed raise.
“Get a investor-ready valuation and warm introductions in 30 days.”
An AI-powered platform that generates a defensible valuation range by analyzing non-traditional signals (IP strength, team, market, tech moat) and matches founders with investors open to first-to-market risk, providing a seamless path to SAFE-based fundraising.
Launch on Reddit communities (r/startups, r/entrepreneur, r/venturecapital), Hacker News, IndieHackers, and X via threads sharing the exact valuation frustrations quoted in direct evidence.
Founders may view the output as no more credible than their own arbitrary number; lack of transparency in the AI model could hinder adoption.
Without a critical mass of investors, the matchmaking feature is useless, and building both sides simultaneously is capital-intensive.
Providing valuation ranges could be interpreted as financial advice, requiring licensing or disclaimers that limit marketability.
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoThis idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 8/10 against 6 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
It sits at the intersection of "ai-powered", "early-stage", "equity", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.
